Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian G Feagan

Showing results (101-110 of 464) with videos related to

Pageof 47
Sort By:
Pharmacotherapy|April 18, 2015
Vedolizumab for the treatment of moderately to severely active ulcerative colitisParambir S Dulai, Mahmoud Mosli, Reena Khanna, et al.
Inflammatory Bowel Diseases|June 24, 2022
Comparison of the Relative Sensitivity of Clinical, Endoscopic, and Histologic Remission for Detection of Treatment Efficacy in Ulcerative Colitis TrialsRocio Sedano, Malcolm Hogan, Guangyong Zou, et al.
The American Journal of Gastroenterology|May 21, 2014
Toward a personalized medicine approach to the management of inflammatory bowel diseaseMahmoud H Mosli, William J Sandborn, Richard B Kim, et al.
Journal of Crohn'S & Colitis|February 23, 2018
Efficacy of Vedolizumab in Fistulising Crohn's Disease: Exploratory Analyses of Data from GEMINI 2Brian G Feagan, David Schwartz, Silvio Danese, et al.
Current Treatment Options in Gastroenterology|January 6, 2020
Current Endpoints of Clinical Trials in Ulcerative Colitis: Are They Valid?Robert Battat, Parambir S Dulai, Christopher Ma, et al.
Gastroenterology|August 30, 2017
Effects of Mongersen (GED-0301) on Endoscopic and Clinical Outcomes in Patients With Active Crohn's DiseaseBrian G Feagan, Bruce E Sands, Guillermo Rossiter, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 30, 2007
Mapping from disease-specific measures to utility: an analysis of the relationships between the Inflammatory Bowel Disease Questionnaire and Crohn's Disease Activity Index in Crohn's disease and measures of utilityMartin J Buxton, Loretto A Lacey, Brian G Feagan, et al.
Gastroenterology|August 17, 2014
Converging goals of treatment of inflammatory bowel disease from clinical trials and practiceBarrett G Levesque, William J Sandborn, Joannie Ruel, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 1, 2002
Transfusion practices for elective orthopedic surgeryBrian G Feagan, Cindy J Wong, William C Johnston, et al.
Journal of Crohn'S & Colitis|October 14, 2017
Development of Clinical Prediction Models for Surgery and Complications in Crohn's DiseaseLeonardo Guizzetti, Guangyong Zou, Reena Khanna, et al.
Pageof 47

Showing results (101-110 of 464) with videos related to

Sort By:
Pageof 47
Pharmacotherapy|April 18, 2015
Vedolizumab for the treatment of moderately to severely active ulcerative colitisParambir S Dulai, Mahmoud Mosli, Reena Khanna, et al.
Inflammatory Bowel Diseases|June 24, 2022
Comparison of the Relative Sensitivity of Clinical, Endoscopic, and Histologic Remission for Detection of Treatment Efficacy in Ulcerative Colitis TrialsRocio Sedano, Malcolm Hogan, Guangyong Zou, et al.
The American Journal of Gastroenterology|May 21, 2014
Toward a personalized medicine approach to the management of inflammatory bowel diseaseMahmoud H Mosli, William J Sandborn, Richard B Kim, et al.
Journal of Crohn'S & Colitis|February 23, 2018
Efficacy of Vedolizumab in Fistulising Crohn's Disease: Exploratory Analyses of Data from GEMINI 2Brian G Feagan, David Schwartz, Silvio Danese, et al.
Current Treatment Options in Gastroenterology|January 6, 2020
Current Endpoints of Clinical Trials in Ulcerative Colitis: Are They Valid?Robert Battat, Parambir S Dulai, Christopher Ma, et al.
Gastroenterology|August 30, 2017
Effects of Mongersen (GED-0301) on Endoscopic and Clinical Outcomes in Patients With Active Crohn's DiseaseBrian G Feagan, Bruce E Sands, Guillermo Rossiter, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 30, 2007
Mapping from disease-specific measures to utility: an analysis of the relationships between the Inflammatory Bowel Disease Questionnaire and Crohn's Disease Activity Index in Crohn's disease and measures of utilityMartin J Buxton, Loretto A Lacey, Brian G Feagan, et al.
Gastroenterology|August 17, 2014
Converging goals of treatment of inflammatory bowel disease from clinical trials and practiceBarrett G Levesque, William J Sandborn, Joannie Ruel, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 1, 2002
Transfusion practices for elective orthopedic surgeryBrian G Feagan, Cindy J Wong, William C Johnston, et al.
Journal of Crohn'S & Colitis|October 14, 2017
Development of Clinical Prediction Models for Surgery and Complications in Crohn's DiseaseLeonardo Guizzetti, Guangyong Zou, Reena Khanna, et al.
Pageof 47